We have read the article entitled ‘Transdermal fentanyl patch versus standard analgesia
in postoperative oral submucous fibrosis patients: a triple blinded, randomised control
trial.
1
We want to congratulate the authors for this successful postoperative study on oral
submucous fibrosis (OSMF) and want to contribute to the same subject.To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to British Journal of Oral and Maxillofacial SurgeryAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- Transdermal fentanyl patch versus standard analgesia in postoperative oral submucous fibrosis patients: a triple blinded, randomised control trial.Br J Oral Maxillofac Surg. 2022; 60: 1246-1253
- Oral submucous fibrosis: a contemporary narrative review with a proposed inter-professional approach for an early diagnosis and clinical management.J Otolaryngol Head Neck Surg. 2020; 49: 3
- Transdermal fentanyl in the long-term treatment of cancer pain: a prospective study of 50 patients with advanced cancer of the gastrointestinal tract or the head and neck region.Pain. 1997; 69: 191-198
- Maintenance of increased mouth opening in oral submucous fibrosis patient treated with nasolabial flap technique.Case Rep Dent. 2014; 2014: 842578
- Malignant conversion of oral submucous fibrosis in surgically treated case.J Clin Diagn Res. 2014; 8: ZD31-2
Article info
Publication history
Published online: January 10, 2023
Accepted:
December 10,
2022
Identification
Copyright
© 2023 The British Association of Oral and Maxillofacial Surgeons. Published by Elsevier Ltd. All rights reserved.
